论文信息 - First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer - 字舞流文

First-in-Human Study of PF-05212384 (PKI-587), a Small-Molecule, Intravenous, Dual Inhibitor of PI3K and mTOR in Patients with Advanced Cancer

G. Shapiro | J. Tabernero | E. Kwak | J. Bendell | M. Alsina | I. Braña | B. Houk | K. Pierce | J. Spicer | J. Molina | K. Bell-McGuinn | G. Borzillo | J. Gallo | Lixin Han | R. Millham | Susan S. Pandya